Aprea Therapeutics Inc (NASDAQ:APRE)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - APRE

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - APRE

  • Market Cap$108.900m
  • SymbolNASDAQ:APRE
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS03836J1025

Company Profile

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Latest APRE news

Currently there for this company. Visit our news hub for other news .